TTM
38.3%
YoY change
+33.96pp
Trough year (1995)
-1185.2%
Peak year (2015)
68.0%
Latest annual
39.7%
Operating Margin history chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: 39.7%
Operating Margin change chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: +33.96pp
Operating Margin history table for Gilead Sciences (GILD) from 1990 to 2025
| 2025 | 39.7% | +33.96pp | ||
| 2024 | 5.8% | -22.27pp | ||
| 2023 | 28.0% | +1.18pp | ||
| 2022 | 26.9% | -9.45pp | ||
| 2021 | 36.3% | +19.83pp | ||
| 2020 | 16.5% | -2.61pp | ||
| 2019 | 19.1% | -17.96pp | ||
| 2018 | 37.1% | -17.04pp | ||
| 2017 | 54.1% | -3.92pp | ||
| 2016 | 58.0% | -9.97pp | ||
| 2015 | 68.0% | +6.67pp | ||
| 2014 | 61.3% | +20.94pp | ||
| 2013 | 40.4% | -0.95pp | ||
| 2012 | 41.3% | -3.86pp | ||
| 2011 | 45.2% | -4.65pp | ||
| 2010 | 49.8% | -0.49pp | ||
| 2009 | 50.3% | +0.14pp | ||
| 2008 | 50.2% | -0.97pp | ||
| 2007 | 51.2% | +76.24pp | ||
| 2006 | -25.1% | -79.75pp | ||
| 2005 | 54.7% | +7.31pp | ||
| 2004 | 47.4% | +65.65pp | ||
| 2003 | -18.3% | -35.64pp | ||
| 2002 | 17.4% | +68.98pp | ||
| 2001 | -51.6% | -24.87pp | ||
| 2000 | -26.8% | +3.84pp | ||
| 1999 | -30.6% | +21.23pp | ||
| 1998 | -51.8% | +2.68pp | ||
| 1997 | -54.5% | +53.59pp | ||
| 1996 | -108.1% | +1077.10pp | ||
| 1995 | -1185.2% | -466.82pp | ||
| 1994 | -718.4% | — | ||
| 1992 | -433.3% | -208.33pp | ||
| 1991 | -225.0% | +144.23pp | ||
| 1990 | -369.2% | — |
- 202539.7%+33.96pp
- 20245.8%-22.27pp
- 202328.0%+1.18pp
- 202226.9%-9.45pp
- 202136.3%+19.83pp
- 202016.5%-2.61pp
- 201919.1%-17.96pp
- 201837.1%-17.04pp
- 201754.1%-3.92pp
- 201658.0%-9.97pp
- 201568.0%+6.67pp
- 201461.3%+20.94pp
- 201340.4%-0.95pp
- 201241.3%-3.86pp
- 201145.2%-4.65pp
- 201049.8%-0.49pp
- 200950.3%+0.14pp
- 200850.2%-0.97pp
- 200751.2%+76.24pp
- 2006-25.1%-79.75pp
- 200554.7%+7.31pp
- 200447.4%+65.65pp
- 2003-18.3%-35.64pp
- 200217.4%+68.98pp
- 2001-51.6%-24.87pp
- 2000-26.8%+3.84pp
- 1999-30.6%+21.23pp
- 1998-51.8%+2.68pp
- 1997-54.5%+53.59pp
- 1996-108.1%+1077.10pp
- 1995-1185.2%-466.82pp
- 1994-718.4%—
- 1992-433.3%-208.33pp
- 1991-225.0%+144.23pp
- 1990-369.2%—
Operating Margin values are taken from Gilead Sciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Margin at Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's latest reported operating margin is 38.3%. Operating margin is operating income divided by revenue — the share of each sales dollar left after cost of goods sold and operating expenses (SG&A, R&D), but before interest and taxes. It isolates how profitable the core business is before financing and tax decisions, so it is comparable across companies with different capital structures.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Gilead Sciences (GILD) most recent annual operating margin stands at 39.74% (2025) – expanded 34.0 percentage points year-over-year.
2015 marks the peak operating margin at 68.00%, with the historical low of -1185.19% recorded in 1995.
Gilead Sciences Operating Margin by Year
Gilead Sciences Operating Margin 2025: 39.7%
Gilead Sciences operating margin in 2025 was 39.74%, expanded 34.0 percentage points from 2024.
Gilead Sciences Operating Margin 2024: 5.8%
2024's operating margin for Gilead Sciences came in at 5.78%, contracted 22.3 percentage points from 2023.
Gilead Sciences Operating Margin 2023: 28.0%
Gilead Sciences posted operating margin of 28.05% in 2023, expanded 1.2 percentage points from 2022.
Gilead Sciences Operating Margin 2022: 26.9%
In 2022, Gilead Sciences reported operating margin of 26.87%, contracted 9.5 percentage points from 2021.
Gilead Sciences Operating Margin 2021: 36.3%
Gilead Sciences operating margin in 2021 was 36.32%.
See more financial history for Gilead Sciences (GILD).
Sector peers by Operating Margin
Healthcare peers of Gilead Sciences (GILD), ranked by their latest operating margin
| 45.9% | |
| 45.3% | |
| 31.6% | |
| 27.6% | |
| 27.6% | |
| 26.4% | |
| 23.7% | |
| 4.2% |
- 45.9%
- 45.3%
- 31.6%
- 27.6%
- 27.6%
- 23.7%
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation